Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2018 08:30 ET | Source: INmune Bio, Inc.

Trastuzumab-Resistant HER2 Positive Breast Cancer Reversed By Treatment with INB03

Study Results Presented at San Antonio Breast Cancer Symposium 2018 LA JOLLA, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- INmune Bio, Inc., an immunotherapy company developing treatments to...